Using three cell lines of ER+ phenotype and four cell lines of the TN phenotype, we further showed that the expressed TLR4 was biologically active and hence responding to both PAMPs and DAMPs, primarily in the TN breast cancer cell lines. This evidence concerns the gene TLR4 and breast cancer.